Understanding HoLEP - Advances in Prostate Treatment - Dr Jeevagan Murugesan

Published Date: 01 Mar 2023

Benign prostatic hyperplasia (BPH) is a condition in which the prostate gland enlarges, causing problems or obstruction in urination...

Read Full News

Latest News

Trump's Push for the World's Lowest Drug Prices Hits Snag With Mid-sized Companies

President Donald Trump has promised to make U.S. prescription drug prices the cheapest in the world, but a closely watched Medicaid pilot program could expose the limits of...

Experimental Novartis Radiopharma Drug Shows Promise in Early Study

Novartis said on Sunday that early data from its experimental actinium-based drug showed signs of anti-tumour activity against prostate cancer, including in ⁠patients...

Vasectomy Reversal More Cost-Effective Than IVF

Most couples younger than 40 years can achieve pregnancy within typical $30,000-$40,000 employer fertility benefits with reversal, new research indicates.

US Judge Rejects Bayer Bid to Block Johnson & Johnson Prostate Cancer Drug Claims

A U.S. judge has rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that ⁠its multibillion-dollar drug cuts the risk of...

This Test Could Predict Incontinence Risk After HoLEP

Men with a shorter membranous urethra appear more likely to experience urinary incontinence after laser enucleation for benign prostatic hyperplasia, a new study shows.

Smartphone App Helps Delay Ejaculation

The app improves sexual control and doubles ejaculation latency time in a randomized trial.

Todays Updates

Breast Cancer Incidence Rises in Asian American Women

A cross-sectional population-based study examines trends in invasive breast cancer incidence rates in Asian American, Native Hawaiian, and Pacific Islander ethnic groups.

Todays Updates

Breast Cancer Incidence Rises in Asian American Women

A cross-sectional population-based study examines trends in invasive breast cancer incidence rates in Asian American, Native Hawaiian, and Pacific Islander ethnic groups.

Latest News

President Donald Trump has promised to make U.S. prescription drug prices the cheapest in the world, but a closely watched Medicaid pilot program could expose the limits of...

Novartis said on Sunday that early data from its experimental actinium-based drug showed signs of anti-tumour activity against prostate cancer, including in ⁠patients...

Most couples younger than 40 years can achieve pregnancy within typical $30,000-$40,000 employer fertility benefits with reversal, new research indicates.

A U.S. judge has rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that ⁠its multibillion-dollar drug cuts the risk of...

Men with a shorter membranous urethra appear more likely to experience urinary incontinence after laser enucleation for benign prostatic hyperplasia, a new study shows.

The app improves sexual control and doubles ejaculation latency time in a randomized trial.

News All Time

Weary of Prior Auths? What Would Happen If You Were Paid by the Insurers to Submit Them?

Approving a prior authorization CPT code is what the NYC urologist is requesting.

FDA Approves New Treatment for Women's Simple UTIs.

Now available in the U.S. is an antibiotic that is widely used in other nations. s.

During the Accountable Care Meeting, CMS Officials were pressed on the topic of scanner fraud.

"We would appreciate it if you could give the matter more immediate attention," one ACO member said.

Nivolumab Plus Chemotherapy in First Line Approved for Bladder Cancer.

Combination decreased death risk by 22%.

King Charles III's Operation; COVID-19 Timeline Under Question; FDA Approvals Reach Record High.

The staff of MedPage Today has compiled health news and commentary from around the web.

Noninvasive Treatment Effective in Bladder Cancer That Is Not Muscle-Invasive.

An investigational intrusive solution produced a 79% complete response rate.

For Prostate Cancer at Intermediate Risk, SBRT Is Not Less Effective Than Conventional RT.

Similar results are obtained from treatment lasting one to two weeks as compared to therapy lasting up to seven and a half weeks.

Even in those with HIV, a single dose of antibiotics was able to cure early syphilis.

In a randomized trial, one dosage showed no worse results than a triple-dose regimen.

Should Patients With Advanced Prostate Cancer Get Off the Active Surveillance Train?

Clearly defined rules are needed.

The new first-line standard for advanced bladder cancer was produced by a landmark trial.

When compared to chemotherapy, enfortumab vedotin-pembrolizumab doubles OS and PFS.

AR-Pathway Inhibitor Switch for mCRPC is Superseded by Radionuclide Therapy.

With 177Lu-PSMA-617, the time to radiographic progression was doubled.

An RCT Supports HIF-2a Inhibition in Advanced RCC.

Belzutifan outperforms everolimus in the event of immunotherapy-TKI failure.

Cabazitaxel Lower-Dose Schedule Is Viable for Elderly Patients With mCRPC.

Neutropenia of grade three or above, with a twelve-fold reduction in neutropenic consequences.

Removing Cancer Survivors From Oncologic Treatment.

A new approach to care is required.

CAR T-Cell Therapy for Renal Cell Carcinoma: "We're Not There Yet".

Possibility of standard of care following current therapies, but significant barriers still need to be overcome.

In severe cases of renal cell carcinoma, tyrosine kinase inhibitor activity is present.

Reactions to the "special medication" zanzalintinib in patients exposed and not exposed to cabozantinib.

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

Recently released national data on drug use and abuse among Americans.

Participate and win cash vouchers

Get updates on the latest events happening around the world

2.

Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor

3.

In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.

4.

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

5.

Cancer patients want financial screening early in care, study finds

1.

Beyond the Biopsy: Decoding Tumor Biology Through the Lens of Radiogenomics

2.

How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?

3.

Revolutionizing Cancer Treatment: The Promise of Bevacizumab Injections

4.

Advanced Directions in Hematology for Better Care

5.

Iron Chelation Therapy: Preventing Long-Term Treatment Toxicities

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia

2.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

5.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Understanding HoLEP - Advances in Prostate Treatment - Dr Jeevagan Murugesan

Latest News

Trump's Push for the World's Lowest Drug Prices Hits Snag With Mid-sized Companies

Experimental Novartis Radiopharma Drug Shows Promise in Early Study

Vasectomy Reversal More Cost-Effective Than IVF

US Judge Rejects Bayer Bid to Block Johnson & Johnson Prostate Cancer Drug Claims

This Test Could Predict Incontinence Risk After HoLEP

Smartphone App Helps Delay Ejaculation

Todays Updates

Breast Cancer Incidence Rises in Asian American Women

Todays Updates

Breast Cancer Incidence Rises in Asian American Women

Latest News

News All Time

Weary of Prior Auths? What Would Happen If You Were Paid by the Insurers to Submit Them?

FDA Approves New Treatment for Women's Simple UTIs.

During the Accountable Care Meeting, CMS Officials were pressed on the topic of scanner fraud.

Nivolumab Plus Chemotherapy in First Line Approved for Bladder Cancer.

King Charles III's Operation; COVID-19 Timeline Under Question; FDA Approvals Reach Record High.

Noninvasive Treatment Effective in Bladder Cancer That Is Not Muscle-Invasive.

For Prostate Cancer at Intermediate Risk, SBRT Is Not Less Effective Than Conventional RT.

Even in those with HIV, a single dose of antibiotics was able to cure early syphilis.

Should Patients With Advanced Prostate Cancer Get Off the Active Surveillance Train?

The new first-line standard for advanced bladder cancer was produced by a landmark trial.

AR-Pathway Inhibitor Switch for mCRPC is Superseded by Radionuclide Therapy.

An RCT Supports HIF-2a Inhibition in Advanced RCC.

Cabazitaxel Lower-Dose Schedule Is Viable for Elderly Patients With mCRPC.

Removing Cancer Survivors From Oncologic Treatment.

CAR T-Cell Therapy for Renal Cell Carcinoma: "We're Not There Yet".

In severe cases of renal cell carcinoma, tyrosine kinase inhibitor activity is present.

Recommended News For You

Early-life exposure to air and light pollution linked to increased risk of pediatric thyroid cancer

Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.

Many women undergo annual mammography, despite biennial screening recommendations

Win for Perioperative Durvalumab in Muscle-Invasive Bladder Cancer

Do I qualify for a cancer clinical trial?

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

Recently released national data on drug use and abuse among Americans.

Recommended Articles For You

Leukemia: Understanding the Disease and Its Impact on Patients

Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance

Spatially Targeted Intratumoral Therapeutics: Mechanisms, Clinical Applications, and Future Directions

Understanding Carcinoid Tumors: Diagnosis, Symptoms, and Treatment Options

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Featured News

Featured Articles

Featured Events

Featured KOL Videos

Quick Links

Verification

Welcome to Hidoc Dr.